Last reviewed · How we verify
NCT04222738: GINOFF1
The Cardiovascular Effects of Ginger (Zingiber Officinale) in Patients With Type II Diabetes Mellitus
Phase 4 trial testing GINOFF1 in Cardiovascular Benefits of Zingiber Officinale Roscoe in Patients With Type 2 Diabetes Mellitus Before and After 6 Weeks of add-on Therapy in 21 participants. Completed in 31 May 2017.
31 May 2017
Quick facts
| Lead sponsor | Yaounde Central Hospital |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 21 |
| Start date | 1 December 2016 |
| Primary completion | 31 May 2017 |
| Estimated completion | 31 May 2017 |
| Sites | 1 location across Cameroon |
Drugs / interventions tested
- GINOFF1
Conditions studied
- Cardiovascular Benefits of Zingiber Officinale Roscoe in Patients With Type 2 Diabetes Mellitus Before and After 6 Weeks of add-on Therapy — all drugs for Cardiovascular Benefits of Zingiber Officinale Roscoe in Patients With Type 2 Diabetes Mellitus Before and After 6 Weeks of add-on Therapy →
Sponsor
Yaounde Central Hospital
Who can join
Adults 21 to 75, any sex, with Cardiovascular Benefits of Zingiber Officinale Roscoe in Patients With Type 2 Diabetes Mellitus Before and After 6 Weeks of add-on Therapy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study was the evaluation of cardiovascular benefits of Zingiber officinale Roscoe in patients with type 2 diabetes mellitus before and after 6 weeks of add-on therapy.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Cardiometabolic effects of ZingiberOfficinale Roscoe extracts in Type 2 diabetic Cameroonians patients after six weeks of add-on Therapy : A single clinical-arm trial.
Nganou-Gnindjio CN, Ngati Nyonga D, Wafeu GS, Nga EN, et al · · 2022 · cited 4× · PMID 35039142 · DOI 10.1016/j.ancard.2021.09.010
Verify or expand the search:
- PubMed search for NCT04222738
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Yaounde Central Hospital trials
Trials by the same sponsor.
- NCT04790214 — Effect of a Cardiac Rehabilitation Program on Chronic Heart Failure Patients in Yaoundé, Cameroon · NA · unknown
- NCT04715295 — Safety and Efficacy of Doxycycline and Rivaroxaban in COVID-19 · Phase 4 · unknown
- NCT05013346 — Characteristics of Young-onset Diabetes in Sub-Saharan Africa (YODA) Study · unknown
- NCT04255992 — Short Term Cardiovascular Effects and Oxidative Status of Calcium and Vitamin D Supplementation of Postmenopausal Hypert · Phase 4 · completed
- NCT04254042 — Comparative Effects of Perindopril and Zofenopril on Blood Pressure Control and Oxidative Status Blacks Hypertensive Pat · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04222738 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yaounde Central Hospital
- Last refreshed: 10 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04222738.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing